@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@Sri_Baqri 4 years ago
A new @CellCellPress Special Review issue on #Therapeutics: #Cancer, #autoimmune #disease, #vaccines, #RareDisease #MachineLearning and #medicine, #CRISPR #AAV, #pharma #neurodegeneration - its all @ http://bit.ly/2V9mLV1 https://t.co/TXz3prO4yu
@xconomy.com 4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening